MODIFICATION TO TRIAGE B-TYPE NATRIURETIC PEPTIDE (BNP) TEST

Test, Natriuretic Peptide

BIOSITE INCORPORATED

The following data is part of a premarket notification filed by Biosite Incorporated with the FDA for Modification To Triage B-type Natriuretic Peptide (bnp) Test.

Pre-market Notification Details

Device IDK032235
510k NumberK032235
Device Name:MODIFICATION TO TRIAGE B-TYPE NATRIURETIC PEPTIDE (BNP) TEST
ClassificationTest, Natriuretic Peptide
Applicant BIOSITE INCORPORATED 11030 ROSELLE ST. San Diego,  CA  92121
ContactJeffrey R Dahlen
CorrespondentJeffrey R Dahlen
BIOSITE INCORPORATED 11030 ROSELLE ST. San Diego,  CA  92121
Product CodeNBC  
CFR Regulation Number862.1117 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2003-07-21
Decision Date2004-01-28
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.